INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Hospital Virgen del Puerto
Plasencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Puerto (20)
2024
2020
-
Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial
Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25
2019
2017
-
Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group
British Journal of Haematology, Vol. 178, Núm. 5, pp. 699-708
2016
-
A path analysis of patient dependence and caregiver burden in Alzheimer's disease
International Psychogeriatrics, Vol. 28, Núm. 7, pp. 1133-1141
-
Bence Jones proteinuria in smoldering multiple myeloma as a predictor marker of progression to symptomatic multiple myeloma
Leukemia, Vol. 30, Núm. 10, pp. 2026-2031
-
Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis
Blood, Vol. 127, Núm. 24, pp. 3035-3039
2015
-
Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy Epidemiology of musculoskeletal disorders
BMC Musculoskeletal Disorders, Vol. 16, Núm. 1
-
The cellular origin and malignant transformation of Waldenström macroglobulinemia
Blood, Vol. 125, Núm. 15, pp. 2370-2380
2014
-
Hairy cell leukemia treated initially with purine analogs: A retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)
Leukemia and Lymphoma, Vol. 55, Núm. 5, pp. 1007-1012
-
Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: New criteria for differential diagnosis and risk stratification
Leukemia, Vol. 28, Núm. 1, pp. 166-173
2012
-
Response to imatinib mesylate in patients with hypereosinophilic syndrome
International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326
2011
-
The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis
Blood, Vol. 117, Núm. 13, pp. 3613-3616
2008
-
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: The influence of prior exposure to rituximab on outcome. A GEL/TAMO study
Haematologica, Vol. 93, Núm. 12, pp. 1829-1836
2005
-
Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer
Investigational New Drugs, Vol. 23, Núm. 3, pp. 243-251
2004
2003
-
A multicenter phase II study of irinotecan in patients with advanced colorectal cancer previously treated with 5-fluorouracil
Clinical Colorectal Cancer, Vol. 3, Núm. 3, pp. 174-179
-
Immunophenotypic analysis of Waldenstrom's macroglobulinemia
Seminars in Oncology, Vol. 30, Núm. 2, pp. 187-195
2000
-
Estimación de ingresos y estancias inadecuadas en un hospital comarcal
Revista Clinica Espanola, Vol. 200, Núm. 12, pp. 654-658